I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 17 studies | 40% ± 18% | |
| classical monocyte | 8 studies | 26% ± 12% | |
| non-classical monocyte | 5 studies | 29% ± 6% | |
| natural killer cell | 4 studies | 20% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 20% ± 3% | |
| plasma cell | 4 studies | 29% ± 11% | |
| epithelial cell | 4 studies | 31% ± 11% | |
| plasmacytoid dendritic cell | 4 studies | 25% ± 7% | |
| conventional dendritic cell | 3 studies | 36% ± 15% | |
| hematopoietic precursor cell | 3 studies | 21% ± 2% | |
| myeloid cell | 3 studies | 25% ± 9% | |
| macrophage | 3 studies | 19% ± 3% | |
| retinal cone cell | 3 studies | 44% ± 1% | |
| retinal rod cell | 3 studies | 26% ± 4% | |
| endothelial cell | 3 studies | 21% ± 7% | |
| dendritic cell | 3 studies | 25% ± 1% |
